U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SILTUXIMAB
T4H8FMA7IM
US Approved Rx (2014)
First approved in 2014
General
Names
12
Classification
8
Identifiers
17
Subunits
4
Related Substances
1
SILTUXIMAB
T4H8FMA7IM
US Approved Rx (2014)
First approved in 2014
General
Approval Year
2014
494
Names
12
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SILTUXIMAB
Official Name
English
SILTUXIMAB [VANDF]
Common Name
English
SILTUXIMAB [USAN]
Common Name
English
siltuximab [INN]
Common Name
English
CNTO-328
Code
English
Showing 1 to 5 of 12 entries
Previous
1
2
3
Next
Classification
8
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Positive
EU ORPHAN DRUG
Positive
Treatment of Castleman's disease
EU-Orphan Drug
EU/3/07/508
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of multiple myeloma
FDA ORPHAN DRUG
200505
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of Castleman's disease
FDA ORPHAN DRUG
200605
LYMPHOPROLIFERATIVE DISORDERS
EMA EPAR
DISEASES
BLOOD AND LYMPHATIC DISEASES
LYMPHATIC DISEASES
LYMPHOPROLIFERATIVE DISORDERS
GIANT LYMPH NODE HYPERPLASIA
EMA ASSESSMENT REPORTS
SYLVANT (AUTHORIZED: GIANT LYMPH NODE HYPERPLASIA)
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
17
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
T4H8FMA7IM
PRIMARY
MERCK INDEX
m11726
PRIMARY
NCI_THESAURUS
C61084
PRIMARY
LACTMED
Siltuximab
PRIMARY
CAS
541502-14-1
PRIMARY
Showing 1 to 5 of 17 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
T4H8FMA7IM
SILTUXIMAB
